S14:E2 – Oncology Morning Commute: A Review of the Science Behind Multicancer Early Detection Tests

Hematology / Oncology @Point of Care Podcasts

English - December 22, 2022 08:02 - 24 minutes - 33.6 MB
Medicine Health & Fitness checkpointinhibitors cmece endometrialcancer immunotherapy Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: S14:E1 – Oncology Morning Commute: New Approaches to Testing Patients for Cancer

Next Episode: S14:E3 – Oncology Morning Commute: How Can Physicians Use Best Clinical Judgment to Determine Core Drivers for Cancer Screening?

In the second episode of our podcast series on early cancer detection, our faculty take a closer look at multicancer early detection tests and the groundbreaking PATHFINDER study that so far is showing impressive data.

Visit http://www.MorningCommutePodcast.com/CancerEarlyDetect2 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit